Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus by Xu He, Xu He, Xu He, Wei Zhao, Wei Zhao, PeiHang Li, PeiHang Li, YinJiang Zhang, YinJiang Zhang, GuoHua Li, HongYu Su, BiNan Lu, BiNan Lu, ZongRan Pang, ZongRan Pang

Subjects: “…GLP-1…”
Get full text

Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential by Tohada M. AL-Noshokaty, Rehab Abdelhamid, Nourhan M. Abdelmaksoud, Aya Khaled, Mariam Hossam, Razan Ahmed, Toka Saber, Shahd Khaled, Shereen Saeid Elshaer, Ahmed I. Abulsoud

Subjects: “…GLP-1…”
Get full text

Are GLP-1 Analogues a New Solution for the Treatment of NAFLD? by Maria Sudoł, Katarzyna Dąbek, Michał Ochwat, Martyna Piekarska, Anna Skowronek, Aleksandra Kajtel, Gabriela Mierzwa, Zofia Sudoł

Subjects: “…MAFLD, NAFLD, GLP‐1 receptor agonists, GLP‐1 analogues, incretin mimetics.…”
Get full text

Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice by Fang Lv, Xiaoling Cai, Chu Lin, Wenjia Yang, Linong Ji

Subjects: “…GLP-1 receptor agonists…”
Get full text

The Beneficial Effects of GLP-1 Receptor Agonists Other than Their Anti-Diabetic and Anti-Obesity Properties by Chenqi Lu, Cong Xu, Jun Yang

Subjects: “…GLP-1…”
Get full text

Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at? by Miodrag Janić, Sabina Škrgat, Matevž Harlander, Mojca Lunder, Andrej Janež, Anca Pantea Stoian, Mohamed El-Tanani, Viviana Maggio, Manfredi Rizzo

Subjects: Get full text

Reduction of Hepatic Fat Content by Dulaglutide for the Treatment of Diabetes Mellitus: A Two‐Centre Open, Single‐Arm Trial by Chuanfeng Liu, Yu Xin, Yajing Huang, Lili Xu, Ruizhi Zhou, Yangang Wang, Wei Wang

Subjects: “…GLP‐1…”
Get full text

GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death by Wu Li, Wen Lyu, Songjun Liu, Fan Ruan, Xinmei Zhang

Subjects: Get full text

Fasting GLP-1 Levels in Women with PCOS and CAH by Robeva R., Kirilov G., Elenkova A., Zacharieva S.

Subjects: Get full text

GLP-1 Receptor Agonists’ Impact on Fertility - A Review by Joanna Wojda, Katarzyna Lesiczka-Fedoryj, Anna Walczak, Zuzanna Kościuszko, Adam Sobiński, Matylda Czerwonka, Katarzyna Kurza, Julianna Podolec, Silvia Ciraolo, Agnieszka Kulczycka-Rowicka

Subjects: “…GLP-1 analog…”
Get full text

Potential impact of GLP-1 receptor agonists on male fertility: a fable of caution by Stefan S. Du Plessis, Temidayo S. Omolaoye, Walter D. Cardona Maya

Subjects: Get full text

Maintaining Fat-Free Mass and Muscle Mass during obesity therapy with Incretin-Mimetic Drugs by Dariusz Popiela, Karina Urbańska, Łukasz Stojak, Mateusz Grego, Filip Kwiatkowski, Mateusz Baczewski, Katarzyna Grego, Witold Czyż

Subjects: Get full text

Editorial: Insights in obesity: 2023 by Katsunori Nonogaki

Subjects: Get full text

Long-term prognostic impact of glucagon-like peptide-1 receptor agonist before ST-segment elevation myocardial infarction in patients with type 2 diabetes: a nationwide cohort stud... by Jasmine Melissa Madsen, Alexander Krüger Kjaer, Jacob Thomsen Lønborg, Lars Køber, Charlotte Glinge, Reza Jabbari, Thomas Engstrøm

Subjects: Get full text

Efeitos do Orforglipron no tratamento da obesidade by Marcelo José da Silva de Magalhães, Pedro Henrique Martins de Souza, Victória Toledo Oliva Ferreira Silva

Subjects: Get full text

Biotechnology Revolution Shaping the Future of Diabetes Management by Nilima Rajpal Kundnani, Bogdan Lolescu, Anca-Raluca Dinu, Delia Mira Berceanu-Vaduva, Patrick Dumitrescu, Tudor-Paul Tamaș, Abhinav Sharma, Mihaela-Diana Popa

Subjects: Get full text

Novel antidiabetic therapies in patients with peripheral artery disease: current perspective by Miodrag Janić, Miodrag Janić, Miodrag Janić, Viviana Maggio, Andrej Janež, Andrej Janež, Manfredi Rizzo, Manfredi Rizzo

Subjects: Get full text

Integrating 16S rDNA and metabolomics to uncover the therapeutic mechanism of electroacupuncture in type 2 diabetic rats by Zhang Yue, Wang Xiang, Deng Duping, Gong Yuanyuan, Chen Xuanyi, Li Juan, Li Juan, Hong Xiaojuan

Subjects: Get full text

Compounded glucagon-like peptide-1 receptor agonists for weight loss: the direct-to-consumer market in Colorado by Michael J. DiStefano, Mouna Dardouri, Gina D. Moore, Joseph J. Saseen, Kavita V. Nair

Subjects: Get full text

Comparison of glucagon-like peptide-1 receptor agonists vs. placebo on any cardiovascular events in overweight or obese non-diabetic patients: a systematic review and meta-analysis by Raveena Kelkar, Nishad A. Barve, Rohan Kelkar, Sanjeev Kharel, Shalmi Khanapurkar, Rukesh Yadav

Subjects: “…GLP-1 RA…”
Get full text